「Genentech」の共起表現一覧(1語右で並び替え)
該当件数 : 32件
| This effectively granted | Genentech a patent term of 29 years. |
| merate Hoffmann-La Roche now completely owns | Genentech after completing its purchase on March 26, 2 |
| In 1999, | Genentech agreed to pay the University of California, |
| In the 1980s, Cooley took both | Genentech and Amgen public. |
| evelopment by Hoffmann-La Roche's subsidiary | Genentech, and Biogen Idec. |
| It is marketed in the United States by | Genentech and OSI Pharmaceuticals and elsewhere by Roc |
| irst non-university scientist to be hired at | Genentech, and the company's third employee. |
| as a lengthy interference proceeding between | Genentech and Celltech which led to the issuance of a |
| addition, according to a letter released by | Genentech and OSI Pharmaceuticals, some people prescri |
| rated the | Genentech CEO Arthur D. Levinson as the "nicest" CEO o |
| Genentech claimed that they developed Protropin, a gro | |
| rican molecular biologist and is currently a | Genentech Fellow in tumor biology and angiogenesis. |
| In 1990, UCSF sued | Genentech for $400 million in compensation for alleged |
| In 1996, Tanox, Novartis, and | Genentech formed a tripartite partnership to develop t |
| He served as Vice President of | Genentech from 1976 through his retirement in 1991. |
| However, | Genentech has appealed the USPTO's ruling and the pate |
| talist who cofounded the biotechnology giant | Genentech in 1976 with Herbert Boyer. |
| He was hired by | Genentech in 2003 as its senior vice president, Resear |
| In April, 2009, | Genentech Inc. announced a phased voluntary withdrawal |
| Dr. Botstein joined | Genentech, Inc. in 1987 as Vice President-Science. |
| ular Biology at the University of Zurich, at | Genentech Inc. in San Francisco and at the Research In |
| MedImmune, Inc. v. | Genentech, Inc., 549 U.S. 118 (2007) was a decision by |
| Genentech is a pioneer in the field, and it remains on | |
| on Dr. Folkman's hypothesis and developed by | Genentech, Lucentis and Avastin, are now FDA-approved |
| Efalizumab (trade name Raptiva, | Genentech, Merck Serono) is a medication designed to t |
| A humanized anti-IgE antibody from | Genentech, omalizumab, with identical binding characte |
| her Keiichi Itakura, Riggs collaborated with | Genentech scientist Herbert Boyer, and used recombinan |
| Genentech started clinical trials on the drug in Octob | |
| nology industry who, employed at the time by | Genentech, successfully used genetic engineering to co |
| 1982 | Genentech synthetic 'human' insulin approved, largely |
| Riggs, Ph.D, is a geneticist who worked with | Genentech to express the first artificial gene in bact |
| In 1976, Boyer founded | Genentech with venture capitalist Robert A. Swanson. |
こんにちは ゲスト さん
|
ログイン |
Weblio会員(無料)になると
|
こんにちは ゲスト さん
|
ログイン |
Weblio会員(無料)になると
|